ATTO Sale Disclosure
Walsh Colin · SEC Form 4 · Filed Aug 13, 2026
Sale
Calculated transaction value
$4.41K
Walsh Colin Director
ATTO
Transaction date
Aug 5, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 9 days later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 200 shares @ $22.05
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001866174-26-000009
Filing cohort
Transactions in this filing
Showing 15 of 29
Trades
29
Issuers
1
Estimated value
$12.54M
Buys / sales
2 / 23
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 6, 2026 | $8.5M |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $25.81K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $153.55K |
| Attovia Therapeutics, Inc. ATTO Current | Sale | Aug 5, 2026 | $4.41K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $146.15K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $29.34K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $74.91K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $2.21K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $22.93K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $6.25K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $25.77K |